Cardiac vascular calcification and QT interval in ESRD patients: Is there a link?

Blood Purification

Volumn 24, Issue 5-6, 2006, Pages 451-459

  Di Iorio, Biagio R ^a   Bortone, Sara ^a   Piscopo, Carmine ^a   Grimaldi, Pellegrino ^a   Cucciniello, Emanuele ^a   D'Avanzo, Ernesto ^a   Mondillo, Fiorentino ^a   Cillo, Nicola ^a   Bellizzi, Vincenzo ^a  

^a PO 'A landolfi' ^*  (Italy)

Author keywords

Chronic kidney failure; Haemodialysis; QT dispersion; QT interval; Vascular calcification

Indexed keywords

ALBUMIN; CALCIUM; CHOLESTEROL; LOW DENSITY LIPOPROTEIN; PARATHYROID HORMONE; PHOSPHATE; PHOSPHORUS;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD VESSEL CALCIFICATION; CLINICAL ARTICLE; CORRELATION ANALYSIS; DATA ANALYSIS; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEMODIALYSIS; HUMAN; MALE; PHOSPHATE BLOOD LEVEL; PREVALENCE; PRIORITY JOURNAL; QT INTERVAL; UREMIA;

AGE FACTORS; AGED; AGED, 80 AND OVER; BLOOD PROTEINS; CALCINOSIS; CALCIUM; CARDIOVASCULAR DISEASES; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PHOSPHATES; RENAL DIALYSIS; SEX FACTORS; TIME FACTORS; UREMIA;

EID: 33751426334     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000095362     Document Type: Article

References (52)

1. Foley RN, Parfrey PS, Sarnak MJ: Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998;32(5 Suppl 3):S112-S119.
2. Goodman WG, Goldin J, Kuizon BD, et al: Coronary artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 2000;342:1478-1483.
3. Raggi P, Boulay A, Chasan-Taber S, et al: Cardiac calcification in adult hemodialysis patients: a link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol 2002;39:695-701.
4. Blacher J, Guèrin AP, Pannier B, et al: Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 2001;38:938-942.
5. Sigrist M, Bungay P, Taal MW, et al: Vascular calcification and cardiovascular function in chronic kidney disease. Nephrol Dial Transplant 2006;21:707-714.
6. Stewart GA, Gansevoort RT, Mark PB, et al: Electrocardiographic abnormalities and uremic cardiomyopathy. Kidney Int 2005;67:217-226.
7. Day CP, McComb JM, Campbell RW: QT dispersion: an indicator of arrhythmia risk in patients with long QT intervals. Br Heart J 1990;63:342-344.
8. Lee KW, Kligfield P, Okin PM, et al: Determinants of precordial QT dispersion in normal subjects. J Electrocardiol 1998;31(Suppl):S128-S133.
9. Kors JA, van Herpen G, van Bemmel JH: QT dispersion as an attribute of T-loop morphology. Circulation 1999;99:1458-1463.
10. Pharm Bull 2003, No. 5-6.
11. Foley RN, Parfrey PS, Harnett JD, et al: The impact of anemia on cardiomyopathy, morbidity and mortality in ESRD. Am J Kidney Dis 1996;28:53-61.
12. Becker C: Assessment of coronary arteries with CT. Radiol Clin North Am 2002;40:773-782.
13. Agatston A, Janowitz W, Hildner F, et al: Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990;15:827-832.
14. Mailloux LU, Bellucci AG, Wilkes BM, et al: Mortality in dialysis patients: analysis of the causes of death. Am J Kidney Dis 1991;18:326-335.
15. Gruppo Emodialisi e Patologie Cardiovascuolari: Multicentre, cross-sectional study of ventricular arrhythmias in chronically haemodialysed patients. Lancet 1988;332:305-339.
16. Brown JH, Hunt LP, Vites NP, et al: Comparative mortality from cardiovascular disease in patients with chronic renal failure. Nephrol Dial Transplant 1994;9:1136-1142.
17. Foley RN, Parfrey PS: Cardiovascular disease and mortality in ESRD. J Nephrol 1998;11:239-245.
18. Abe S, Yoshizawa M, Nakanishi N, et al: Electrocardiographic abnormalities in patients receiving hemodialysis. Am Heart J 1996;131:1137-1144.
19. Buemi M, Aloisi E, Coppolino G, et al: The effect of two different protocols of potassium haemodiafiltration on QT dispersion. Nephrol Dial Transplant 2005;20:1148-1154.
20. Floccari F, Aloisi E, Nostro L, et al: QTc interval and QTc dispersion during haemodiafiltration. Nephrology (Carlton) 2004;9:335-340.
21. Schouten EG, Dekker JM, Meppelink P, et al: QT interval prolongation predicts cardiovascular mortality in an apparently healthy population. Circulation 1991;84:1516-1523.
22. London G, Guérin A, Marchais S, et al: Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 2003;18:1731-1740.
23. Blacher J, Guérin A, Pannier B, et al: Impact of aortic stiffness on survival in end-stage renal disease. Circulation 1999;99:2434-2439.
24. Kalantar-Zadeh K, Block G, Humphries M, et al: Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int 2003;63:793-808.
25. Stenvinkel P, Pecotis-Filho R, Lindholm B: Coronary artery disease in end-stage renal disease: no longer a simple plumbing problem. J Am Soc Nephrol 2003;14:1927-1939.
26. Sigrist MK, Devlin L, Taal MW, et al: Length of interdialytic interval influences serum calcium and phosphorus concentrations. Nephrol Dial Transplant 2005;20:1643-1646.
27. Moe SM, O'Neill KD, Fineberg N, et al: Assessment of vascular calcification in ESRD patients using spiral CT. Nephrol Dial Transplant 2003;18:1152-1158.
28. Chertow G, Burke S, Raggi P: Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 2002;62:245-252.
29. Wang AY, Wang M, Ho S, et al: Cardiac valvular calcification as a marker of atherosclerosis and arterial calcification in end-stage renal disease. Arch Intern Med 2005;165:327-332.
30. Floege J, Ketteler M: Vascular calcification in patients with end-stage renal disease. Nephrol Dial Transplant 2004;19(Suppl 5):V59-V66.
31. Ammann K, Tyralla K, Gross ML, et al: Special characteristics of atherosclerosis in chronic renal failure. Clin Nephrol 2003;60(Suppl 1):S13-S21.
32. Ketteler M, Westenfeld R, Schlieper G, et al: Pathogenesis of vascular calcification in dialysis patients. Clin Exp Nephrol 2005;9:265-270.
33. McCullough PA, Sandberg KR, Dumler F, et al: Determinants of coronary vascular calcification in patients with coronary kidney disease and end-stage renal disease: a systematic review. J Nephrol 2004;17:205-215.
34. Qunibi WY: Dyslipidemia and progression of cardiovascular calcification in patients with end-stage renal disease. Kidney Int Suppl 2005;95:S43-S50.
35. Zoccali C, Mallamaci F, Tripepi G: Novel cardiovascular risk factors in end-stage renal disease. J Am Soc Nephrol 2004;15(Suppl 1):S77-S80.
36. Lorincz I, Matyus J, Zilahi Z, et al: QT dispersion in patients with end-stage renal failure and during hemodialysis. J Am Soc Nephrol 1999;10:1297-1302.
37. Gipstein R, Coburn J, Adams D, et al: Calciphylaxis in man. Arch Intern Med 1976;136:1273-1280.
38. Sharples EJ, Pereira D, Summers S, et al: Coronary artery calcification measured with electron beam computerized tomography correlates poorly with coronary artery angiography in dialysis patients. Kidney Int 2004;43:313-319.
39. Beaubien ER, Pylypchuk GB, Akhtar J, et al: Value of corrected QT interval dispersion in identifying patients initiating dialysis at Increased risk of total and cardiovascular mortality. Am J Kidney Dis 2002;39:834-842.
40. Honda H, Qureshi AR, Heinburger O, et al: Serum albumin, C-reactive protein, interleukin 6, and fetuin as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD. Am J Kidney Dis 2006;47:139-148.
41. Salles G, Leocàdio S, Bloch K, et al: Combined QT interval and voltage criteria improve left ventricular hypertrophy detection in resistant hypertension. Hypertension 2005;46:1207-1212.
42. Mayet J, Shahy M, McGrath K, et al: Left ventricular hypertrophy and QT dispersion in hypertension. Hypertension 1996;28:791-796.
43. Oikarinen L, Nieminen MS, Vitasalo M, et al: Relation of QT interval and QT dispersion to echocardiographic left ventricular hypertrophy and geometric pattern in hypertension patients. The LIFE Study. J Hypertens 2001;19:1883-1891.
44. Chapman N, Mayet J, Ozkor M, et al: QT interval and QT dispersion as measures of left ventricular hypertrophy in an unselected hypertensive population. Am J Hypertens 2001;14:455-462.
45. Salles GF, Cardoso CR, Deccache W: Multivariate associates of QT interval paramenters in diabetic patients with arterial hypertension: importance of left ventricular mass and geometric patterns. J Hum Hypertens 2003;17:561-567.
46. Menon V, Sarnak MJ, Greene T, et al: Relationship between homocysteine and mortality in chronic kidney disease. Circulation 2006;113:1572-1577.
47. Kazmi WH, Gilbertson DT, Obrador GT, et al: Effect of comorbidity on the increased mortality associated with early initiation of dialysis. Am J Kidney Dis 2005;46:887-896.
48. Mallamaci F, Tripepi G, Cutrupi S, et al: Prognostic value of combined use of biomarkers of inflammation, endothelial dysfunction, and myocardiopathy in patients with ESRD. Kidney Int 2005;67:2330-2337.
49. De Nicola L, Minutolo R, Chiodini P, et al: Global approach to cardiovascular risk in chronic kidney disease: reality and opportunities for intervention. Kidney Int 2006;69:538-545.
50. Glancy JM, Weston PJ, Bhullar HK, et al: Reproducibility and automatic measurements of QT dispersion. Eur Heart J 1996;17:1035-1039.
51. Zabel M, Klingenheben T, Franz MR, et al: Assessment of QT dispersion for prediction of mortality or arrhythmic events after myocardial infarction: results of a prospective, long-term follow-up study. Circulation 1998;97:2543-2550.
52. Raizada V, Skipper B, Luo W, et al: Renin-angiotensin polymorphisms and QT interval prolongation in ESRD. Kidney Int 2005;68:1186-1189.